FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2756584855> ?p ?o ?g. }

• W2756584855 endingPage "667" @default.
• W2756584855 startingPage "661" @default.
• W2756584855 abstract "The aim of the present work is to answer the question is it possible to replace the ester prodrug candesartan cilexetil (CC) by its active metabolite candesartan (C) to bypass the in vivo variable effect of esterase enzymes. A comparative physicochemical evaluation was conducted through solubility, dissolution, and stability studies; additionally, ex vivo permeation and in vivo studies were assessed. C demonstrated higher solubility over CC at alkaline pH. Moreover, dissolution testing using the pharmacopeial method showed better release profile of C even in the absence of surfactant in the testing medium. Both drugs demonstrated a slight degradation in acidic pH after short-term stability. Instead, shifting to alkaline pH of 6.5 and 7.4 showed superiority of C solution stability compared to CC solution. The ex vivo permeation results demonstrated that the parent compound C has a significant (P < 0.05) enhanced permeation compared to its prodrug from CC, that agreed with in vivo results in which C suspension reached significantly (P < 0.05) higher C max of 1.39 ± 0.59 μg/mL at T max of 0.66 ± 0.11 h, while CC suspension reached C max of 0.47 ± 0.22 μg/mL at T max of 2.00 ± 0.27 h, a lag period of 40 min is needed prior to detection of any absorbed CC in plasma. Those findings are not in agreement with the previously reported rationale on the prodrug formation owing to the poor permeability of the parent compound, suggesting the possibility of marketing the parent drug candesartan for clinical use similarly to azilsartan and its prodrug." @default.
• W2756584855 created "2017-10-06" @default.
• W2756584855 creator A5007116804 @default.
• W2756584855 creator A5014703914 @default.
• W2756584855 creator A5054821696 @default.
• W2756584855 date "2017-09-25" @default.
• W2756584855 modified "2023-10-06" @default.
• W2756584855 title "Comparative Pharmaceutical Evaluation of Candesartan and Candesartan Cilexetil: Physicochemical Properties, In Vitro Dissolution and Ex Vivo In Vivo Studies" @default.
• W2756584855 cites W1964772644 @default.
• W2756584855 cites W1969477622 @default.
• W2756584855 cites W1978409124 @default.
• W2756584855 cites W1979835524 @default.
• W2756584855 cites W2005122786 @default.
• W2756584855 cites W2006334961 @default.
• W2756584855 cites W2059142487 @default.
• W2756584855 cites W2059183805 @default.
• W2756584855 cites W2063909696 @default.
• W2756584855 cites W2073161080 @default.
• W2756584855 cites W2097957153 @default.
• W2756584855 cites W2131860317 @default.
• W2756584855 cites W2148756948 @default.
• W2756584855 cites W2168235742 @default.
• W2756584855 cites W2213042592 @default.
• W2756584855 cites W2301809797 @default.
• W2756584855 cites W2344217318 @default.
• W2756584855 cites W2412162716 @default.
• W2756584855 cites W2532251020 @default.
• W2756584855 cites W3192973584 @default.
• W2756584855 doi "https://doi.org/10.1208/s12249-017-0879-x" @default.
• W2756584855 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28948575" @default.
• W2756584855 hasPublicationYear "2017" @default.
• W2756584855 type Work @default.
• W2756584855 sameAs 2756584855 @default.
• W2756584855 citedByCount "6" @default.
• W2756584855 countsByYear W27565848552018 @default.
• W2756584855 countsByYear W27565848552019 @default.
• W2756584855 countsByYear W27565848552020 @default.
• W2756584855 countsByYear W27565848552021 @default.
• W2756584855 crossrefType "journal-article" @default.
• W2756584855 hasAuthorship W2756584855A5007116804 @default.
• W2756584855 hasAuthorship W2756584855A5014703914 @default.
• W2756584855 hasAuthorship W2756584855A5054821696 @default.
• W2756584855 hasBestOaLocation W27565848551 @default.
• W2756584855 hasConcept C108215921 @default.
• W2756584855 hasConcept C112705442 @default.
• W2756584855 hasConcept C150903083 @default.
• W2756584855 hasConcept C155574463 @default.
• W2756584855 hasConcept C170493617 @default.
• W2756584855 hasConcept C178790620 @default.
• W2756584855 hasConcept C185592680 @default.
• W2756584855 hasConcept C202751555 @default.
• W2756584855 hasConcept C207001950 @default.
• W2756584855 hasConcept C26291073 @default.
• W2756584855 hasConcept C2780036600 @default.
• W2756584855 hasConcept C2908929049 @default.
• W2756584855 hasConcept C41625074 @default.
• W2756584855 hasConcept C43617362 @default.
• W2756584855 hasConcept C50670333 @default.
• W2756584855 hasConcept C55493867 @default.
• W2756584855 hasConcept C71924100 @default.
• W2756584855 hasConcept C86803240 @default.
• W2756584855 hasConcept C88380143 @default.
• W2756584855 hasConcept C98274493 @default.
• W2756584855 hasConceptScore W2756584855C108215921 @default.
• W2756584855 hasConceptScore W2756584855C112705442 @default.
• W2756584855 hasConceptScore W2756584855C150903083 @default.
• W2756584855 hasConceptScore W2756584855C155574463 @default.
• W2756584855 hasConceptScore W2756584855C170493617 @default.
• W2756584855 hasConceptScore W2756584855C178790620 @default.
• W2756584855 hasConceptScore W2756584855C185592680 @default.
• W2756584855 hasConceptScore W2756584855C202751555 @default.
• W2756584855 hasConceptScore W2756584855C207001950 @default.
• W2756584855 hasConceptScore W2756584855C26291073 @default.
• W2756584855 hasConceptScore W2756584855C2780036600 @default.
• W2756584855 hasConceptScore W2756584855C2908929049 @default.
• W2756584855 hasConceptScore W2756584855C41625074 @default.
• W2756584855 hasConceptScore W2756584855C43617362 @default.
• W2756584855 hasConceptScore W2756584855C50670333 @default.
• W2756584855 hasConceptScore W2756584855C55493867 @default.
• W2756584855 hasConceptScore W2756584855C71924100 @default.
• W2756584855 hasConceptScore W2756584855C86803240 @default.
• W2756584855 hasConceptScore W2756584855C88380143 @default.
• W2756584855 hasConceptScore W2756584855C98274493 @default.
• W2756584855 hasIssue "2" @default.
• W2756584855 hasLocation W27565848551 @default.
• W2756584855 hasLocation W27565848552 @default.
• W2756584855 hasOpenAccess W2756584855 @default.
• W2756584855 hasPrimaryLocation W27565848551 @default.
• W2756584855 hasRelatedWork W1976716531 @default.
• W2756584855 hasRelatedWork W1990414540 @default.
• W2756584855 hasRelatedWork W2010129857 @default.
• W2756584855 hasRelatedWork W2601938933 @default.
• W2756584855 hasRelatedWork W2908799665 @default.
• W2756584855 hasRelatedWork W2913831029 @default.
• W2756584855 hasRelatedWork W2957242515 @default.
• W2756584855 hasRelatedWork W4293104065 @default.
• W2756584855 hasRelatedWork W4313826511 @default.
• W2756584855 hasRelatedWork W2183263379 @default.

• next